Filament BioSolutions Announces Collaboration with Ajinomoto for the Development of FB-2710 for Radiation-Induced Oral Mucositis NEW YORK, July 10, 2018 (GLOBE NEWSWIRE) -- Filament BioSolutions, a development-stage company focused on delivering innovative therapeutics for nutritional deficiencies, announced today continued...

Filament Biosolutions Partners with Leading Canadian Academic Centers for $9.1M Project to Study Precision Nutritional Therapies for Inflammatory Bowel Disease NEW YORK, Jan. 31, 2018 (GLOBE NEWSWIRE) -- Filament BioSolutions, Inc., a company focused on the development and commercialization of clinical nutrition therapeutics announced a collaboration with...

Filament BioSolutions Announces Exclusive License Agreement with Leading Academic Institutions for Beverage to Prevent Kidney Stones NEW YORK, Oct. 13, 2016 (GLOBE NEWSWIRE) -- Filament BioSolutions Inc., a company focused on the development and commercialization of innovative clinical nutrition products announced today an...

Filament BioSolutions Announces Strategic Partnership With Ajinomoto to Develop a Portfolio of Evidence-Based Medical Foods NEW YORK, Jan. 11, 2016 (GLOBE NEWSWIRE) -- Filament BioSolutions Inc., a medical nutrition company, announced today a broad partnership with Ajinomoto North America, Inc., a subsidiary of Ajinomoto...